These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
364 related articles for article (PubMed ID: 33355191)
1. Racial/Ethnic Disparities in Survival after Breast Cancer Diagnosis by Estrogen and Progesterone Receptor Status: A Pooled Analysis. John EM; McGuire V; Kurian AW; Koo J; Shariff-Marco S; Gomez SL; Cheng I; Keegan THM; Kwan ML; Bernstein L; Vigen C; Wu AH Cancer Epidemiol Biomarkers Prev; 2021 Feb; 30(2):351-363. PubMed ID: 33355191 [TBL] [Abstract][Full Text] [Related]
2. Reproductive characteristics, menopausal status, race and ethnicity, and risk of breast cancer subtypes defined by ER, PR and HER2 status: the Breast Cancer Etiology in Minorities study. John EM; Koo J; Phipps AI; Longacre TA; Kurian AW; Ingles SA; Wu AH; Hines LM Breast Cancer Res; 2024 May; 26(1):88. PubMed ID: 38822357 [TBL] [Abstract][Full Text] [Related]
3. Racial/ethnic differences in breast cancer survival by inflammatory status and hormonal receptor status: an analysis of the Surveillance, Epidemiology, and End Results data. Schinkel JK; Zahm SH; Jatoi I; McGlynn KA; Gallagher C; Schairer C; Shriver CD; Zhu K Cancer Causes Control; 2014 Aug; 25(8):959-68. PubMed ID: 24839049 [TBL] [Abstract][Full Text] [Related]
4. Disparities in race/ethnicity and socioeconomic status: risk of mortality of breast cancer patients in the California Cancer Registry, 2000-2010. Parise CA; Caggiano V BMC Cancer; 2013 Oct; 13():449. PubMed ID: 24083624 [TBL] [Abstract][Full Text] [Related]
5. The role of human epidermal growth factor receptor 2 in the survival of women with estrogen and progesterone receptor-negative, invasive breast cancer: the California Cancer Registry, 1999-2004. Brown M; Tsodikov A; Bauer KR; Parise CA; Caggiano V Cancer; 2008 Feb; 112(4):737-47. PubMed ID: 18189290 [TBL] [Abstract][Full Text] [Related]
6. The joint contribution of tumor phenotype and education to breast cancer survival disparity between Hispanic and non-Hispanic white women. Boone SD; Baumgartner KB; Joste NE; Pinkston CM; Yang D; Baumgartner RN Cancer Causes Control; 2014 Mar; 25(3):273-82. PubMed ID: 24337810 [TBL] [Abstract][Full Text] [Related]
7. Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry. Bauer KR; Brown M; Cress RD; Parise CA; Caggiano V Cancer; 2007 May; 109(9):1721-8. PubMed ID: 17387718 [TBL] [Abstract][Full Text] [Related]
8. Intersection of Race/Ethnicity and Socioeconomic Status in Mortality After Breast Cancer. Shariff-Marco S; Yang J; John EM; Kurian AW; Cheng I; Leung R; Koo J; Monroe KR; Henderson BE; Bernstein L; Lu Y; Kwan ML; Sposto R; Vigen CL; Wu AH; Keegan TH; Gomez SL J Community Health; 2015 Dec; 40(6):1287-99. PubMed ID: 26072260 [TBL] [Abstract][Full Text] [Related]
9. Smoking and breast cancer risk by race/ethnicity and oestrogen and progesterone receptor status: the Multiethnic Cohort (MEC) study. Gram IT; Park SY; Maskarinec G; Wilkens LR; Haiman CA; Le Marchand L Int J Epidemiol; 2019 Apr; 48(2):501-511. PubMed ID: 30668861 [TBL] [Abstract][Full Text] [Related]
10. Influence of clinical, societal, and treatment variables on racial differences in ER-/PR- breast cancer survival. Roseland ME; Schwartz K; Ruterbusch JJ; Lamerato L; Krajenta R; Booza J; Simon MS Breast Cancer Res Treat; 2017 Aug; 165(1):163-168. PubMed ID: 28547656 [TBL] [Abstract][Full Text] [Related]
11. Mortality risk of black women and white women with invasive breast cancer by hormone receptors, HER2, and p53 status. Ma H; Lu Y; Malone KE; Marchbanks PA; Deapen DM; Spirtas R; Burkman RT; Strom BL; McDonald JA; Folger SG; Simon MS; Sullivan-Halley J; Press MF; Bernstein L BMC Cancer; 2013 May; 13():225. PubMed ID: 23642215 [TBL] [Abstract][Full Text] [Related]
12. Racial disparity in survival from estrogen and progesterone receptor-positive breast cancer: implications for reducing breast cancer mortality disparities. Rauscher GH; Silva A; Pauls H; Frasor J; Bonini MG; Hoskins K Breast Cancer Res Treat; 2017 Jun; 163(2):321-330. PubMed ID: 28251385 [TBL] [Abstract][Full Text] [Related]
13. Racial/ethnic differences in postmenopausal breast cancer risk by hormone receptor status: The multiethnic cohort study. Sarink D; White KK; Loo LWM; Wu AH; Wilkens LR; Le Marchand L; Park SY; Setiawan VW; Merritt MA Int J Cancer; 2022 Jan; 150(2):221-231. PubMed ID: 34486728 [TBL] [Abstract][Full Text] [Related]
14. Disparities in the risk of the ER/PR/HER2 breast cancer subtypes among Asian Americans in California. Parise C; Caggiano V Cancer Epidemiol; 2014 Oct; 38(5):556-62. PubMed ID: 25172158 [TBL] [Abstract][Full Text] [Related]
15. Racial disparities in individual breast cancer outcomes by hormone-receptor subtype, area-level socio-economic status and healthcare resources. Akinyemiju T; Moore JX; Ojesina AI; Waterbor JW; Altekruse SF Breast Cancer Res Treat; 2016 Jun; 157(3):575-86. PubMed ID: 27255533 [TBL] [Abstract][Full Text] [Related]
16. Race and risk of subsequent aggressive breast cancer following ductal carcinoma in situ. Liu Y; West R; Weber JD; Colditz GA Cancer; 2019 Sep; 125(18):3225-3233. PubMed ID: 31120565 [TBL] [Abstract][Full Text] [Related]
17. Trends in use of contralateral prophylactic mastectomy by racial/ethnic group and ER/PR status among patients with breast cancer: A SEER population-based study. Brown D; Shao S; Jatoi I; Shriver CD; Zhu K Cancer Epidemiol; 2016 Jun; 42():24-31. PubMed ID: 26999400 [TBL] [Abstract][Full Text] [Related]
18. Frequency distributions of breast cancer characteristics classified by estrogen receptor and progesterone receptor status for eight racial/ethnic groups. Chu KC; Anderson WF; Fritz A; Ries LA; Brawley OW Cancer; 2001 Jul; 92(1):37-45. PubMed ID: 11443607 [TBL] [Abstract][Full Text] [Related]
19. Mediation of Racial and Ethnic Disparities in Estrogen/Progesterone Receptor-Negative Breast Cancer by Socioeconomic Position and Reproductive Factors. Rauscher GH; Campbell RT; Wiley EL; Hoskins K; Stolley MR; Warnecke RB Am J Epidemiol; 2016 May; 183(10):884-93. PubMed ID: 27076668 [TBL] [Abstract][Full Text] [Related]
20. Race and the prognostic influence of p53 in women with breast cancer. Dookeran KA; Dignam JJ; Holloway N; Ferrer K; Sekosan M; McCaskill-Stevens W; Gehlert S Ann Surg Oncol; 2012 Jul; 19(7):2334-44. PubMed ID: 22434242 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]